Nuveen
HIMS icon

Nuveen’s Hims & Hers Health HIMS Stock Holding History

Nuveen’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2M Buy
783,594
+105,474
+16% +$2.83M 0.01% 1079
2026
Q1 		$14.1M Buy
678,120
+60,167
+10% +$1.42M ﹤0.01% 1348
2025
Q4 		$20.1M Sell
617,953
-189,673
-23% -$8.12M 0.01% 1145
2025
Q3 		$45.8M Sell
807,626
-443,226
-35% -$22.7M 0.01% 661
2025
Q2 		$62.4M Sell
1,250,852
-725,573
-37% -$32.8M 0.02% 526
2025
Q1 		$58.4M Sell
1,976,425
-932,808
-32% -$34.7M 0.02% 565
2024
Q4 		$70.3M Sell
2,909,233
-509,252
-15% -$12.6M 0.02% 511
2024
Q3 		$63M Sell
3,418,485
-11,116
-0.3% -$199K 0.02% 554
2024
Q2 		$69.2M Sell
3,429,601
-144,813
-4% -$2.41M 0.02% 510
2024
Q1 		$55.3M Buy
3,574,414
+28,128
+0.8% +$317K 0.02% 595
2023
Q4 		$31.6M Buy
3,546,286
+423,251
+14% +$3.13M 0.01% 862
2023
Q3 		$19.6M Buy
3,123,035
+229,820
+8% +$1.71M 0.01% 1049
2023
Q2 		$27.2M Buy
2,893,215
+1,168,534
+68% +$11.6M 0.01% 882
2023
Q1 		$17.1M Buy
1,724,681
+364
+0% +$3.19K 0.01% 1148
2022
Q4 		$11.1M Sell
1,724,317
-277,378
-14% -$1.58M ﹤0.01% 1425
2022
Q3 		$11.2M Buy
2,001,695
+1,501,568
+300% +$9.05M ﹤0.01% 1412
2022
Q2 		$2.27M Buy
500,127
+404,153
+421% +$1.72M ﹤0.01% 2374
2022
Q1 		$481K Buy
95,974
+13,467
+16% +$66.6K ﹤0.01% 3028
2021
Q4 		$540K Buy
82,507
+14,123
+21% +$102K ﹤0.01% 3059
2021
Q3 		$516K Buy
+68,384
New +$579K ﹤0.01% 3164

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen's HIMS Position: Q2 2026 in Review

Nuveen increased its Hims & Hers Health (HIMS) stake by 16% in Q2 2026, buying an estimated $2.83M and bringing the position to 783,594 shares worth $27.2M. The position accounts for 0.01% of the portfolio, ranked #1079.

Nuveen first reported a position in HIMS in Q3 2021 and has held it in 20 quarters since. The position peaked at $70.3M in Q4 2024. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Nuveen held 783,594 shares of Hims & Hers Health worth $27.2M as of Q2 2026.
  • Nuveen bought 105,474 Hims & Hers Health shares in Q2 2026, an estimated $2.83M.
  • Hims & Hers Health made up 0.01% of Nuveen's portfolio in Q2 2026, its #1079 holding.
  • Nuveen first reported a position in Hims & Hers Health in Q3 2021 and has held it in 20 quarters since.
  • Nuveen's Hims & Hers Health position peaked at $70.3M in Q4 2024.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.